Influenza vaccination and Guillain Barre syndrome

Clinical Immunology : the Official Journal of the Clinical Immunology Society
Mark R GeierArthur C Zahalsky

Abstract

Acute and severe Guillain Barre Syndrome (GBS) cases reported following influenza vaccine to the Vaccine Adverse Events Reporting System (VAERS) database from 1991 through 1999 were examined. Endotoxin concentrations were measured using the Limulus amebocyte lysate assay in influenza vaccines. There were a total of 382 cases of GBS reported to the VAERS database following influenza vaccination (male/female ratio, 1.2). The median onset of GBS following influenza vaccine was 12 days (interquartile range, 7 days to 21 days). There was an increased risk of acute GBS (relative risk, 4.3; 95% confidence interval, 3.0 to 6.4) and severe GBS (relative risk, 8.5; 95% confidence interval, 3.7 to 18.9) in comparison to an adult tetanus-diphtheria (Td) vaccine control group. There were maximums in the incidence of GBS following influenza vaccine that occurred approximately every third year (1993, 1996, and 1998) and statistically significant variation in the incidence of GBS among different influenza manufacturers. Influenza vaccines contained from a 125- to a 1250-fold increase in endotoxin concentrations in comparison to an adult Td vaccine control and endotoxin concentrations varied up to 10-fold among different lots and manufacturers ...Continue Reading

References

Jan 11, 1979·Nature·M Kadlubowski, R A Hughes
Jan 1, 1981·Annals of Neurology·A IqbalB G Arnason
Jun 25, 1981·The New England Journal of Medicine·E S HurwitzR C Holman
Oct 1, 1995·Annals of Internal Medicine·P A GrossR A Levandowski
Oct 9, 1998·Viral Immunology·L Kucerova
Dec 17, 1998·The New England Journal of Medicine·T LaskyR T Chen
Mar 30, 2000·Infectious Disease Clinics of North America·D StamboulianN Cox
Mar 16, 2001·Expert Opinion on Pharmacotherapy·M D Khare, M Sharland

❮ Previous
Next ❯

Citations

Mar 17, 2007·Zeitschrift für Rheumatologie·K MindenJ-P Haas
Oct 7, 2004·Current Allergy and Asthma Reports·Benjamin J Song, Rohit K Katial
Jan 31, 2008·Clinical Reviews in Allergy & Immunology·V PordeusY Shoenfeld
Oct 5, 2010·Clinical Reviews in Allergy & Immunology·Eitan IsraeliYehuda Shoenfeld
May 26, 2010·Critical Care : the Official Journal of the Critical Care Forum·Joel V Chua, Wilbur H Chen
Jan 1, 2011·ISRN Neurology·Diogo Fraxino de AlmeidaRafael de Figueiredo Radaeli
Mar 12, 2004·Expert Opinion on Pharmacotherapy·David A Geier, Mark R Geier
Jun 19, 2012·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Nizar SouayahDaniel L Menkes
Apr 6, 2004·Clinics in Chest Medicine·Thomas Similowski, Christian Straus
Sep 28, 2006·Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society·Joon-Shik Moon, Nizar Souayah
Feb 14, 2013·Journal of the Royal Army Medical Corps·G Vacchiano, G Vyshka
Jul 15, 2005·Annals of the New York Academy of Sciences·Victor S GurevichMargarita V Levaya
Sep 1, 2019·British Journal of Clinical Pharmacology·Cosby A StoneElizabeth J Phillips
Jun 6, 2017·Journal of Korean Medical Science·Yong Shik ParkBum Chun Suh
Oct 13, 2017·The EPMA Journal·Maria VadalàBeniamino Palmieri
Feb 4, 2021·Pharmacoepidemiology and Drug Safety·Chongliang LuoYong Chen
Mar 2, 2021·Journal of the American Medical Informatics Association : JAMIA·Jingcheng DuCui Tao
Sep 25, 2021·Human Vaccines & Immunotherapeutics·Feng WangJian Wang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.